Supernus, Inc.

US$26.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SUPNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 5.67%
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.13
PE TTM 7.363
TSR TTM 14.79%
Mkt cap US$5.434B
ROIC 272.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$30
12.81%
(74.99%)
Hold 10|5|10|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.28
0.30
0.32
0.36
10.75%
17.59%
24.77%
26.25%
Revenue$M
555.9
552.5
581.6
574.4
(4.17%)
(1.82%)
3.15%
2.50%
Peers (US$5.434B)
Cap (US$)
PE
5.568B
42.33x
Capital
TTM
5Y
10Y
Leveragex
1.145
(0.453)
(0.393)
EBIT/Intx
1.104
0.235
0.278
Own earn%
(20.44)
10.21
11.30
Sh yield%
49.84
27.23
27.98
Owners
Insiders/Inst%
5.52
51.45
Short interest%
1.89
SBC / revenue%
0.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
6–14
$1 testx
—
Incr. ROIC%
3